期刊
AMERICAN JOURNAL OF PREVENTIVE MEDICINE
卷 49, 期 3, 页码 402-408出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.amepre.2015.02.019
关键词
-
资金
- National Institute of Drug Abuse [DA-036510, DA 036510-S1]
- Second Air Force, the leadership branch for training in the U.S. Air Force
- Pfizer
- National Institutes of Health
Introduction: The prevalence of electronic cigarette (e-cigarette) use is increasing markedly in the general population. Yet, remarkably little research exists to examine these ongoing trends in at-risk populations, and nothing is known about the prevalence of e-cigarette use among military personnel. The purpose of the current study is to provide recent (2013-2014) data on the prevalence of regular e-cigarette use in a population of recruits prior to their entry into the U.S. military. Methods: The study utilized a cross-sectional assessment of e-cigarette and other tobacco and nicotine-containing product (TNCP) use in 2013-2014 among 10,043 U.S. Air Force (USAF) recruits in Technical Training. Chi-square tests, the Cochran-Armitage test for trend, and logistic regression models tested differences and trends across time for e-cigarette use. Results: The rate of e-cigarette use among recruits was 5.2%, which doubled (3% to 6.5%, p < 0.0001) across a 1-year period. E-cigarette use was associated with increased odds of all measured TNCPs, as well as dual and poly use (all p < 0.0001). Conclusions: Rates of e-cigarette use are slightly higher in young USAF recruits than in the general population, and e-cigarette users are likely to be using other TNCPs in tandem. Although additional work is needed to understand the reasons for this concomitant use, this is a necessary first step to understanding e-cigarette use prevalence in military populations. Historic trends suggest that, like general populations, e-cigarette use is on the rise for those entering the USAF and should be monitored to inform future prevention programming. (C) 2015 American Journal of Preventive Medicine
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据